How have SCLP shares performed in 2024?

Scancell's stock was trading at GBX 10.50 at the start of the year. Since then, SCLP shares have decreased by 10.3% and is now trading at GBX 9.42. View the best growth stocks for 2024 here .

How were Scancell's earnings last quarter?

Scancell Holdings plc (LON:SCLP) issued its earnings results on Friday, January, 31st. The company reported ($0.56) earnings per share (EPS) for the quarter.

What other stocks do shareholders of Scancell own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Scancell investors own include KAZ Minerals (KAZ) , Standard Chartered (STAN) , Petropavlovsk (POG) , AorTech International (AOR) , Ascential (ASCL) , Advanced Oncotherapy (AVO) , Empyrean Energy (EME) , Lloyds Banking Group (LYG) , Aminex (AEX) and Sound Energy (SOU) .

How do I buy shares of Scancell?

Shares of SCLP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. Compare Top Brokerages Here .

LON:SCLP

Scancell (SCLP) Share Price, News & Analysis

→ This company has increased its dividend every year for 54 years (From DTI) (Ad)

Free SCLP Stock Alerts

GBX 9.41

-0.14 (-1.47%)

(As of 01:17 PM ET)

Compare

Today's Range: 9.40
▼
9.65
50-Day Range: 9.55
▼
11.95
52-Week Range: 7.59
▼
18.30

Volume: 138,144 shs
Average Volume: 431,535 shs
Market Capitalization: £87.31 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Competitors Headlines Insider Trades

Get Scancell alerts:

Ad The Bull Report

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

About Scancell Stock (LON:SCLP)

Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer. It also develops Modi-1, a citrullinated peptides vaccine that is in phase I/II clinical trials for the treatment of solid tumors including triple negative breast, ovarian, renal, and head and neck cancers; and Modi-2, which targets homocitrullinated cancer antigens. In addition, the company focuses to develop SCOV1 and SCOV2 COVIDITY, a DNA vaccine against the SARS-CoV-2 virus. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom.

SCLP Stock Price History

30 days | 90 days | 365 days | Advanced Chart

SCLP Stock News Headlines

April 12, 2024 | americanbankingnews.com

Scancell (LON:SCLP) Stock Passes Below 200-Day Moving Average of $11.76

April 12, 2024 | americanbankingnews.com

Scancell (LON:SCLP) Shares Pass Below 200 Day Moving Average of $11.76

April 19, 2024 | Darwin (Ad)

2024's Must-Have Guide: Master Crypto Investment Today

The cryptocurrency revolution is here with Bitcoin soaring past the $70,000 milestone—a clear indicator of the booming digital currency market. Are you prepared to navigate these exciting yet complex waters? Introducing "Navigating the Future: A Comprehensive Guide to Cryptocurrency Investments in 2024." This free digital guide is your essential resource for understanding and capitalizing on cryptocurrency investments, tailored for both newcomers and seasoned investors. (**By clicking the link you are subscribing to The Conservative Investor Newsletter and may receive up to 2 additional free bonus subscriptions. Unsubscribing is easy.)

March 4, 2024 | finance.yahoo.com

With 47% stake, Scancell Holdings plc (LON:SCLP) seems to have captured hedge funds investors' interest

February 23, 2024 | benzinga.com

Scancell Holdings Stock (OTC:SCNLF), Insider Trading Activity

January 22, 2024 | lse.co.uk

Scancell Holdings Share Chat

January 4, 2024 | proactiveinvestors.com

Scancell: US investment bank resumes coverage with punchy price target

December 18, 2023 | uk.finance.yahoo.com

Scancell Holdings plc (SCP.F)

April 19, 2024 | The Bull Report (Ad)

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

December 13, 2023 | finance.yahoo.com

The past year for Scancell Holdings (LON:SCLP) investors has not been profitable

December 1, 2023 | proactiveinvestors.com

Scancell fundraiser brings in £10.7m after it is 'upsized'

November 2, 2023 | proactiveinvestors.com

Analysts encouraged by Scancell’s strong year-end trading statement

November 1, 2023 | proactiveinvestors.com

Scancell melanoma trial data chosen for poster presentation at SITC

October 31, 2023 | uk.investing.com

Scancell makes strong progress with lead immunotherapy assets

October 2, 2023 | uk.news.yahoo.com

Scancell shares are on fire! Should I buy?

September 25, 2023 | finance.yahoo.com

Hedge funds investors are Scancell Holdings plc's (LON:SCLP) biggest bettors and were rewarded after last week's UK£25m market cap gain

September 20, 2023 | finance.yahoo.com

Scancell CEO hails "exciting" high response rate to melanoma treatment

September 19, 2023 | proactiveinvestors.com

Scancell jumps 23% after trial data; analysts hail results

September 19, 2023 | proactiveinvestors.com

Scancell jump 23% after trial data; analysts hail results

September 7, 2023 | proactiveinvestors.com

Scancell appoints head of business development

August 23, 2023 | fool.com

Scancell Plc (LSE: SCLP)

July 31, 2023 | proactiveinvestors.com

Scancell passes 'important milestone' with cancer trial expansion

July 11, 2023 | finance.yahoo.com

Scancell Holdings "well-financed" and continuing to pursue deals

July 6, 2023 | finance.yahoo.com

Investing in Scancell Holdings (LON:SCLP) three years ago would have delivered you a 146% gain

June 2, 2023 | proactiveinvestors.com

Scancell updates on progress ahead of ASCO poster presentation

April 18, 2023 | proactiveinvestors.com

Scancell says its Head of Clinical Operations to make AACR poster presentation

March 13, 2023 | proactiveinvestors.com

Scancell has no exposure to Silicon Valley Bank, company assures stakeholders

See More Headlines

Receive SCLP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Scancell and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 1/31/2020
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: LON
Sector: Medical
Industry: Biotechnology
Sub-Industry: N/A
Current Symbol: LON:SCLP
CUSIP: N/A
CIK: N/A
Web: www.scancell.co.uk
Phone: +44-115-8231863
Fax: N/A
Employees: 51
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): GBX (0.01)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: £-9,530,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: -269.84%
Return on Assets: -37.22%

Debt

Debt-to-Equity Ratio: 61.41
Current Ratio: 8.63
Quick Ratio: 13.01

Sales & Book Value

Annual Sales: £5.27 million
Price / Sales: 16.58
Cash Flow: GBX 1.20 per share
Price / Cash Flow: 7.86
Book Value: GBX (1) per share
Price / Book: -9.42

Miscellaneous

Outstanding Shares: 927,820,000
Free Float: N/A
Market Cap: £87.40 million
Optionable: Not Optionable
Beta: 0.34

Beginners Guide To Retirement Stocks

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

Prof. Lindy Gillian Durrant Ph.D. (Age 67)
Founder, CEO, Chief Scientific Officer & Director
Comp: $369.12k
Dr. Sally Elizabeth Adams (Age 63)
Executive Officer
Comp: $253.51k
Mr. Sathijeevan Nirmalananthan (Age 38)
CFO & Director
Dr. Samantha Paston Ph.D.
Head of Translational Research
Dr. Adrian Parry Ph.D.
Head of Manufacturing
Dr. Mandeep Sehmi
Head of Business Development
Dr. Callum Scotthasbeen
Head of Development
Mr. Keith Charles Green
Company Secretary

Key Competitors

View All Competitors

SCLP Stock Analysis - Frequently Asked Questions

How have SCLP shares performed in 2024?: Scancell's stock was trading at GBX 10.50 at the start of the year. Since then, SCLP shares have decreased by 10.3% and is now trading at GBX 9.42.
View the best growth stocks for 2024 here.
How were Scancell's earnings last quarter?: Scancell Holdings plc (LON:SCLP) issued its earnings results on Friday, January, 31st. The company reported ($0.56) earnings per share (EPS) for the quarter.
What other stocks do shareholders of Scancell own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Scancell investors own include KAZ Minerals (KAZ), Standard Chartered (STAN), Petropavlovsk (POG), AorTech International (AOR), Ascential (ASCL), Advanced Oncotherapy (AVO), Empyrean Energy (EME), Lloyds Banking Group (LYG), Aminex (AEX) and Sound Energy (SOU).
How do I buy shares of Scancell?: Shares of SCLP stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

This page (LON:SCLP) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial